402 related articles for article (PubMed ID: 15755900)
41. MEIS1 regulates early erythroid and megakaryocytic cell fate.
Zeddies S; Jansen SB; di Summa F; Geerts D; Zwaginga JJ; van der Schoot CE; von Lindern M; Thijssen-Timmer DC
Haematologica; 2014 Oct; 99(10):1555-64. PubMed ID: 25107888
[TBL] [Abstract][Full Text] [Related]
42. Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny.
Pineault N; Helgason CD; Lawrence HJ; Humphries RK
Exp Hematol; 2002 Jan; 30(1):49-57. PubMed ID: 11823037
[TBL] [Abstract][Full Text] [Related]
43. Signal peptide-CUB-EGF-like repeat-containing protein 1-promoted FLT3 signaling is critical for the initiation and maintenance of MLL-rearranged acute leukemia.
Sahoo BK; Lin YC; Tu CF; Lin CC; Liao WJ; Li FA; Li LH; Mou KY; Roffler SR; Wang SP; Yeh CT; Yao CY; Hou HA; Chou WC; Tien HF; Yang RB
Haematologica; 2023 May; 108(5):1284-1299. PubMed ID: 36005562
[TBL] [Abstract][Full Text] [Related]
44. Dual actions of Meis1 inhibit erythroid progenitor development and sustain general hematopoietic cell proliferation.
Cai M; Langer EM; Gill JG; Satpathy AT; Albring JC; KC W; Murphy TL; Murphy KM
Blood; 2012 Jul; 120(2):335-46. PubMed ID: 22665933
[TBL] [Abstract][Full Text] [Related]
45. Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia.
Rombouts EJ; Pavic B; Löwenberg B; Ploemacher RE
Blood; 2004 Jul; 104(2):550-7. PubMed ID: 15054042
[TBL] [Abstract][Full Text] [Related]
46. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential.
Wong P; Iwasaki M; Somervaille TC; So CW; Cleary ML
Genes Dev; 2007 Nov; 21(21):2762-74. PubMed ID: 17942707
[TBL] [Abstract][Full Text] [Related]
47. Transplantable cell lines generated with NUP98-Hox fusion genes undergo leukemic progression by Meis1 independent of its binding to DNA.
Pineault N; Abramovich C; Humphries RK
Leukemia; 2005 Apr; 19(4):636-43. PubMed ID: 15744344
[TBL] [Abstract][Full Text] [Related]
48. GSK-3 promotes conditional association of CREB and its coactivators with MEIS1 to facilitate HOX-mediated transcription and oncogenesis.
Wang Z; Iwasaki M; Ficara F; Lin C; Matheny C; Wong SH; Smith KS; Cleary ML
Cancer Cell; 2010 Jun; 17(6):597-608. PubMed ID: 20541704
[TBL] [Abstract][Full Text] [Related]
49. Pbx1 restrains myeloid maturation while preserving lymphoid potential in hematopoietic progenitors.
Ficara F; Crisafulli L; Lin C; Iwasaki M; Smith KS; Zammataro L; Cleary ML
J Cell Sci; 2013 Jul; 126(Pt 14):3181-91. PubMed ID: 23660001
[TBL] [Abstract][Full Text] [Related]
50. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation.
Ferrando AA; Armstrong SA; Neuberg DS; Sallan SE; Silverman LB; Korsmeyer SJ; Look AT
Blood; 2003 Jul; 102(1):262-8. PubMed ID: 12637319
[TBL] [Abstract][Full Text] [Related]
51. The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia.
Arabanian LS; Johansson P; Staffas A; Nilsson T; Rouhi A; Fogelstrand L; Palmqvist L
Leuk Res; 2018 Dec; 75():61-68. PubMed ID: 30384975
[TBL] [Abstract][Full Text] [Related]
52. Identification and characterization of Hoxa9 binding sites in hematopoietic cells.
Huang Y; Sitwala K; Bronstein J; Sanders D; Dandekar M; Collins C; Robertson G; MacDonald J; Cezard T; Bilenky M; Thiessen N; Zhao Y; Zeng T; Hirst M; Hero A; Jones S; Hess JL
Blood; 2012 Jan; 119(2):388-98. PubMed ID: 22072553
[TBL] [Abstract][Full Text] [Related]
53. Gene expression profiling and candidate gene resequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes.
Novak RL; Harper DP; Caudell D; Slape C; Beachy SH; Aplan PD
Exp Hematol; 2012 Dec; 40(12):1016-27. PubMed ID: 22885519
[TBL] [Abstract][Full Text] [Related]
54. Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1.
Pineault N; Abramovich C; Ohta H; Humphries RK
Mol Cell Biol; 2004 Mar; 24(5):1907-17. PubMed ID: 14966272
[TBL] [Abstract][Full Text] [Related]
55. A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1.
Knoepfler PS; Bergstrom DA; Uetsuki T; Dac-Korytko I; Sun YH; Wright WE; Tapscott SJ; Kamps MP
Nucleic Acids Res; 1999 Sep; 27(18):3752-61. PubMed ID: 10471746
[TBL] [Abstract][Full Text] [Related]
56.
Wang W; Li H; Huang M; Wang X; Li W; Qian X; Jing L
Open Biol; 2022 Oct; 12(10):220172. PubMed ID: 36285442
[No Abstract] [Full Text] [Related]
57. PBX3 is an important cofactor of HOXA9 in leukemogenesis.
Li Z; Zhang Z; Li Y; Arnovitz S; Chen P; Huang H; Jiang X; Hong GM; Kunjamma RB; Ren H; He C; Wang CZ; Elkahloun AG; Valk PJ; Döhner K; Neilly MB; Bullinger L; Delwel R; Löwenberg B; Liu PP; Morgan R; Rowley JD; Yuan CS; Chen J
Blood; 2013 Feb; 121(8):1422-31. PubMed ID: 23264595
[TBL] [Abstract][Full Text] [Related]
58. Meis1 regulates the metabolic phenotype and oxidant defense of hematopoietic stem cells.
Kocabas F; Zheng J; Thet S; Copeland NG; Jenkins NA; DeBerardinis RJ; Zhang C; Sadek HA
Blood; 2012 Dec; 120(25):4963-72. PubMed ID: 22995899
[TBL] [Abstract][Full Text] [Related]
59. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells.
Kawagoe H; Humphries RK; Blair A; Sutherland HJ; Hogge DE
Leukemia; 1999 May; 13(5):687-98. PubMed ID: 10374871
[TBL] [Abstract][Full Text] [Related]
60. Distal regulation of c-myb expression during IL-6-induced differentiation in murine myeloid progenitor M1 cells.
Zhang J; Han B; Li X; Bies J; Jiang P; Koller RP; Wolff L
Cell Death Dis; 2016 Sep; 7(9):e2364. PubMed ID: 27607579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
